Keith Skubitz
14PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Dec 30, 2025
Evolution of CEACAM1 N Domain Biologically Active Sites in Primates.Keith M Skubitz, Wolfgang Zimmermann
|Jan 25, 2025
Clinical Benefit of Pegylated Liposomal Doxorubicin and High Prevalence of Pre-Existing Psychiatric Conditions in Patients with Desmoid-Type Fibromatosis.Andrea Espejo Freire, Keith M Skubitz
|Apr 13, 2023
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma.Natalie K Heater, Scott Okuno, Steven Robinson
|Jul 27, 2022
Prospective Trial of Neutrophil/Lymphocyte Ratio and Other Blood Counts as Biomarkers of Survival among Patients with High-Grade Soft Tissue Sarcomas Treated with Pegylated Liposomal Doxorubicin and Ifosfamide.Keith M Skubitz, Evidio Domingo-Musibay, Bruce R Lindgren
|Mar 28, 2022
Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy.Devon Miller, John A Livingston, Yeonhee Park
Pageof 3
Frequent Collaborators
2 joint publications
Wolfgang Zimmermann
2 joint publications
Angela C Hirbe
2 joint publications
Brian Van Tine
2 joint publications
Mark Agulnik
1 joint publications
Brian L Samuels
1 joint publications
Neeta Somaiah
1 joint publications
Evidio Domingo-Musibay
1 joint publications
Asima Bhattacharyya
1 joint publications
John E Shively
1 joint publications
Varun Monga
